Phase II/III study of Fosbretabulin in patients with Glioblastoma multiforme
Phase of Trial: Phase II/III
Latest Information Update: 03 Feb 2016
At a glance
- Drugs Fosbretabulin (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 03 Feb 2016 According to an Oxigene media release, the company will not initiate this study in 2016 because most of their current efforts for developing CA4P will be on FOCUS (see CT profile 700257531).
- 01 Oct 2015 New trial record
- 29 Sep 2015 According to Oxigene media release, company is planning to initiate this trial in the second half of 2016.